youtube_live
Q1 2026 daromadi • 1 kundan keyin
Tafsilotlarchevron_right
AMGN:NASDAQ
Amgen
337,38 US$
arrow_downward
-0,64%(-2,19) 1K
29-apr, 14:36:47 (GMT-4) · USD
search
Barcha belgilar
1K
5K
1O
6O
YBB
1Y
5Y
MAKS
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoAMGN tikeri uchun statistika yaratilmoqda...
Ochish
335,01 US$
Yuqori
339,12 US$
Past
333,55 US$
Bozor kapitali
182,08 mlrd
Oʻrtacha hajm
2,60 mln
Hajmi
1,40 mln
Dividend
2,99%
Choraklik dividendlar
2,52 US$
Eks-dividend sanasi
15-may, 2026
P/E koeffitsiyenti
23,71
52 haftalik eng yuqori
391,29 US$
52 haftalik eng past
261,43 US$
Aksiya boʻyicha daromad
14,23 US$
Beta
0,47
Muomaladagi aksiyalar
539,69 mln
Xodimlar soni
32 ming
Yangiliklar
Internetdagi manbalardan
MarketBeat
·
5 soat oldin
Amgen Inc. $AMGN Shares Purchased by Vest Financial LLC
Yahoo Finance
·
5 soat oldin
Earnings To Watch: Amgen (AMGN) Reports Q1 Results Tomorrow
Trefis
·
8 soat oldin
How Will Amgen Stock React To Its Upcoming Earnings?
Meyka
·
9 soat oldin
AMGN Earnings Preview: $4.73 EPS Expected April 30
Profil
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA for treatment of osteoporosis and bone diseases, Enbrel for treatment of autoimmune diseases, Repatha for treatment of hyperlipidemia, Otezla for treatment of psoriasis and psoriatic arthritis, Tepezza to treat Graves' ophthalmopathy, Evenity to treat osteoporosis, Kyprolis to treat cancer, Nplate to regulate platelet production, and Aranesp to stimulate erythropoiesis.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health.
The company is ranked 134th on the Fortune 500 and 202nd on the Forbes Global 2000. Wikipedia
Amgen haqida
CEORobert A. Bradway
Xodimlar soni31,5 ming
Asos solingan8-apr, 1980
Bosh ofislarTauzand-Oks, Kaliforniya, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytamgen.com
AI kontentda xatolar boʻlishi mumkin. Batafsil